Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity.

作者: M. Haim Erder , James E. Signorovitch , Juliana Setyawan , Hongbo Yang , Kejal Parikh

DOI: 10.3111/13696998.2012.689270

关键词:

摘要: AbstractObjectives:To illustrate how claims data can be used to (1) develop outcome scores that predict response a traditional treatment and (2) estimate the economic impact of individualized assignment newer based on score. An example application is two treatments for attention deficit hyperactivity disorder (ADHD): osmotic-release oral system methylphenidate (OROS-MPH) lisdexamfetamine dimesylate (LDX).Methods:Adolescents with ADHD initiating OROS-MPH (n = 6320) or LDX (n = 6394) were selected from MarketScan database. A model was developed predicting risk switching/augmentation using multiple baseline characteristics. The applied an independent sample stratify patients by their predicted and, within each stratum, ADHD-related total costs compared between inverse probability weighting.Results:The prediction resulted in ...

参考文章(29)
Scott D Solomon, Lu Tian, Tianxi Cai, Hajime Uno, L. J. Wei, Lihui Zhao, Stratifying Subjects for Treatment Selection with Censored Event Time Data from a Comparative Study ,(2010)
Cynthia A Reuben, Patricia N Pastor, Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. Vital and health statistics. Series 10, Data from the National Health Survey. pp. 1- 14 ,(2008)
David J. Heal, Sharon L. Smith, Robert L. Findling, ADHD: current and future therapeutics Current topics in behavioral neurosciences. ,vol. 9, pp. 361- 390 ,(2011) , 10.1007/7854_2011_125
Adrián V. Hernández, Eric Boersma, Gordon D. Murray, J. Dik F. Habbema, Ewout W. Steyerberg, Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? American Heart Journal. ,vol. 151, pp. 257- 264 ,(2006) , 10.1016/J.AHJ.2005.04.020
Richard Peto, Misleading subgroup analyses in GISSI. American Journal of Cardiology. ,vol. 66, pp. 771- ,(1990) , 10.1016/0002-9149(90)91149-Z
Johannes AN Dorresteijn, Frank LJ Visseren, Paul M Ridker, Annemarie MJ Wassink, Nina P Paynter, Ewout W Steyerberg, Yolanda van der Graaf, Nancy R Cook, None, Estimating treatment effects for individual patients based on the results of randomised clinical trials BMJ. ,vol. 343, ,(2011) , 10.1136/BMJ.D5888
Mark L Wolraich, Charles J Wibbelsman, Thomas E Brown, Steven W Evans, Edward M Gotlieb, John R Knight, E Clarke Ross, Howard H Shubiner, Esther H Wender, Timothy Wilens, Attention-Deficit/Hyperactivity Disorder Among Adolescents: A Review of the Diagnosis, Treatment, and Clinical Implications Pediatrics. ,vol. 115, pp. 1734- 1746 ,(2005) , 10.1542/PEDS.2004-1959
Wedad Hanna, Testing for HER2 status. Oncology. ,vol. 61, pp. 22- 30 ,(2001) , 10.1159/000055398
Stuart J. Pocock, Susan E. Assmann, Laura E. Enos, Linda E. Kasten, Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Statistics in Medicine. ,vol. 21, pp. 2917- 2930 ,(2002) , 10.1002/SIM.1296